Shares ofBioTelemetry(NASDAQ: BEAT), a medical device company focused primarily on mobile cardiac monitoring, are up more than 16% as of 11:45 a.m. EDT on Wednesday. The huge jump is attributable to ...

Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story stocks' without revenue, let alone profit. And in their study titled Who Falls Prey ...

BioTelemetry BEAT recently announced the receipt of CE mark for its Holter analysis software. This approval is expected to exclusively strengthen the company’s foothold in the growing Holter ...

Philips announced this past week that it will acquire BioTelemetry, a provider of remote cardiac diagnostics and monitoring, for $2.8 billion. The transaction is expected to be completed in the first ...

BioTelemetry (BEAT) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.52 per share a year ago. These figures ...

BioTelemetry, a technology company focused on health information delivery, has acquired Telcare, a digital diabetes management platform. Telcare developed the first FDA-cleared cellular enabled blood ...

BIOTELEMETRY ($BEAT) posted quarterly earnings results on Thursday, March 13th. The company reported earnings of -$0.18 per share, beating estimates of -$0.19 by $0. ...

Scaling down electronics isn't only important when building consumer devices, it also has a hufe impact on the world of implantable medical devices. However, as with all things technological, ...

BioTelemetry gained as much as 18% on Friday after news that the cardiac-diagnostics company will be acquired by Dutch company Royal Philips for $2.8 billion. Shares of BioTelemetry rose from Thursday ...

Shares jump on the news that a major insurance company has decided to offer coverage on mobile cardiac telemetry devices. BioTelemetry is on a roll this year. The company's revenue and profits ...